Andelyn Biosciences is a Contract Development and Manufacturing Organisation (CDMO) that specialises in gene therapy with a focus on viral vector manufacturing. The company delivers a comprehensive suite of services that cater to the pharmaceutical industry, including the development and production of advanced therapeutics. With a commitment to quality and innovation, Andelyn Biosciences is well-positioned to support clients through the complexities of bringing gene therapies to market.

Services include:
- Cell and Gene Therapy
- Drug Substance Manufacturing (API)
- Drug Product Formulation (FDF)
- Research & Development
- Regulatory Services
- Analytical Methods Development

Andelyn Biosciences is dedicated to advancing healthcare solutions through its extensive service offerings and expertise in the field. For more information, please visit andelynbiosciences.com.